This Solicitation opportunity from California was posted on November 3, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Pharmaceutical Services

Closed

IFB-042-2900205-AAState & Local

Submission Closed12/01/2025, 12:00:00 AM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

Federal

Flu Vaccines and Associated Supplies

Solicitation # HM047626Q0030

The solicitation for Flu Vaccines and Associated Supplies under HM047626Q0030 has been amended to remove the clause 52.219-6 NOTICE OF TOTAL SMALL BUSINESS SET-ASIDE, indicating the procurement is no longer restricted to small businesses. The government has also provided responses to questions received from potential offerors, with the full Q&A attached for reference. The deadline for submitting proposals has been extended to 5:00 p.m. Central Time on August 10, 2026, and all proposal submission requirements have been updated accordingly to reflect this new date. All other terms and conditions of the original solicitation remain in effect. The award will be made to the responsible offeror submitting the lowest price technically acceptable quote, as determined by the LPTA evaluation method. Offerors must review the full solicitation document and Statement of Work, and submit a completed quote sheet as required. The contracting activity is managed by the National Geospatial-Intelligence Agency under the Department of Defense, with the primary point of contact being Kathleen Dee at the provided email and phone number. The place of performance is in Springfield, Virginia, while the issuing office is located in Arnold, Missouri.

National Geospatial-Intelligence Agency

POSTED

DEADLINE

Supply of Vitamin and Mineral Fortified BlendsThe contract pertains to the production and supply of micronutrient-fortified nutritional blends designed to combat vitamin and mineral deficiencies within clinical environments. These products are intended for use in healthcare settings to support patient recovery and nutritional adequacy, particularly in populations at risk of deficiencies. The work is classified under NAICS code 325412, indicating manufacturing of pharmaceutical and botanical products, and is structured as a subcontract, suggesting it is part of a larger procurement effort led by the South East Regional Health Authority under the Government of Jamaica. The solicitation was posted on July 30, 2026, and performance is expected to occur within Jamaica, though specific location details are not provided. The contract does not specify a set-aside designation or point of contact, indicating that further details may be obtained through the provided government portal link.

South East Regional Health Authority

POSTED

DEADLINE

Pharmaceutical Manufacturing – Tolnaftate Powder (USP 1%)The contract calls for the manufacture of Tolnaftate Powder, USP 1%, in 45-gram units, adhering strictly to United States Pharmacopeia standards, Good Manufacturing Practices, and applicable military specifications. Production must include comprehensive batch testing and rigorous quality control measures to ensure consistency, purity, and potency throughout the manufacturing process. All units must meet exacting pharmaceutical and defense-grade requirements, with full traceability and documentation to support regulatory compliance and operational readiness. The solicitation is classified as a subcontract under NAICS code 325412, issued by the Department of Defense through the Medical Supply Chain Pharm FSA. The place of performance is designated as FPO with ZIP code 09570, indicating delivery to a military postal address. The response deadline is August 5, 2026, with the solicitation posted on July 30, 2026, leaving a limited window for qualified manufacturers to submit proposals. While no specific set-aside status or point of contact is provided, interested parties must reference the official DIBBS portal link to access full solicitation details and ensure compliance with all submission requirements.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Dental Bonding Agent SupplyThe contract involves the supply and delivery of a commercial off-the-shelf dental bonding agent known as the Ultra-Etch 4PK Kit, which includes viscous 35% phosphoric acid gel, syringes, and micro tips, all packaged and labeled to meet federal and military compliance standards. The product must be shipped in accordance with strict regulatory requirements to ensure safety, efficacy, and readiness for use in military medical environments. The solicitation is issued under the NAICS code 325412, which corresponds to pharmaceutical and medicine manufacturing, and is managed by the Department of Defense through the Medical Supply Chain FSH. The place of performance is specified as Suffolk, Virginia, with a zip code of 23435-5000, indicating where the delivered goods will be received and utilized. The solicitation was posted on July 30, 2026, with a response deadline of August 6, 2026, giving potential suppliers just one week to submit their proposals. This is structured as a subcontract opportunity, meaning it is likely part of a larger procurement effort, and no specific set-aside classification has been designated, indicating it is open to all eligible contractors regardless of business size or category. The contract is accessible via the DIBBS platform, which is the Department of Defense’s official system for managing procurement actions, and all submissions must comply with the technical, logistical, and regulatory demands outlined to ensure seamless integration into military dental care protocols.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

Dental Calcium Hydroxide Paste Manufacturing & SupplyThe contract calls for the manufacture and supply of a radiopaque, antibacterial calcium hydroxide paste specifically designed for dental endodontic applications, with strict adherence to FDA and DLA specifications. The scope encompasses the full lifecycle of the product including formulation development, packaging, labeling, and compliance with safety data sheet requirements to ensure regulatory and clinical suitability. The product must meet precise technical standards to function effectively in root canal treatments, combining radiopacity for accurate imaging with antibacterial properties to inhibit microbial growth. Performance is designated to occur in Suffolk, Virginia, with a response deadline of August 6, 2026, and the solicitation is classified as a subcontract under NAICS code 325412 for pharmaceutical and cosmetic manufacturing. The contracting organization is the Department of Defense through its Medical Supply Chain FSH unit, indicating this is a defense-related procurement aimed at equipping military dental services. All materials and processes must align with federal procurement and quality control mandates, and submission is managed through the DLA’s DIBBS platform.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

Pharmaceutical Supplier – BenzoCaine and Menthol LozengesThe contract calls for the supply of six units of CHLORASEPTIC MAX lozenges, each containing 15 mg of benzocaine and 10 mg of menthol, to meet stringent FDA, OSHA, and Department of Defense packaging and labeling requirements. The deliverables must comply with all regulatory standards for pharmaceutical products intended for military and federal use, ensuring safe handling, accurate identification, and proper storage conditions. The solicitation is classified as a subcontract under NAICS code 325412, indicating it falls within the pharmaceutical and medicine manufacturing sector, and is managed by the Department of Defense through the Medical Supply Chain Pharm FSA. Responses are due by August 5, 2026, with the solicitation posted on July 30, 2026, providing a limited window for potential suppliers to prepare and submit proposals. The place of performance is designated as Ellsworth Air Force Base, South Dakota, with a zip code of 57706-4821, indicating the final destination for the lozenges. Although the solicitation number and point of contact details are not provided in the data, the official record is accessible through the DIBBS platform at the specified URL. All parties must adhere to DoD procurement protocols, including documentation, quality assurance, and delivery timelines to meet operational readiness needs.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Supply – Dextrose Injection 5% (NSN 6505013306252)The contract requires the supply and delivery of Dextrose Injection 5%, USP, 1000 mL, in 12-unit cases, in full compliance with U.S. Pharmacopeial standards and the Defense Logistics Agency’s technical specifications. The product, identified by NSN 6505013306252, is intended for federal medical use and must meet stringent quality, packaging, and labeling requirements to ensure safety and efficacy. Performance is to be executed at the FPO mail facility with ZIP code 96669, reflecting the logistical nature of military medical supply distribution. The solicitation, issued under the NAICS code 325412 for pharmaceutical preparation manufacturing, is structured as a subcontract opportunity managed by the Department of Defense’s Medical Supply Chain Pharmaceutical FSA. Responses are due by August 5, 2026, with the solicitation posted on July 30, 2026, providing a seven-day window for interested vendors to submit proposals through the DIBBS platform.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Supplier – Lidocaine Hydrochloride and Epinephrine InjectionThe contract involves the supply of Lidocaine Hydrochloride and Epinephrine Injection in predetermined packaging units, requiring full compliance with FDA regulations, United States Pharmacopeia standards, and military-specific packaging requirements. The product must be manufactured and packaged to meet the strict quality and safety benchmarks set by these authorities to ensure suitability for use in military and defense medical applications. All deliveries are to be fulfilled to the specified place of performance, identified as FPO with ZIP code 96691, indicating delivery to a U.S. military postal address. Subcontractors responding to this solicitation must submit proposals by the deadline of August 5, 2026, following the NAICS code 325412 for pharmaceutical preparation manufacturing. The agency managing the requirement is the Department of Defense, specifically under the Medical Supply Chain Pharm FSA, which oversees the procurement of critical medical pharmaceuticals for military use. The contract is classified as a subcontract and is posted on the DIBBS system, where interested parties can access the official solicitation details through the provided link. There is no set-aside designation, meaning all eligible vendors may compete without restriction based on business size or socioeconomic status.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of DEA-Regulated Veterinary Euthanasia DrugThe contract pertains to the manufacture and delivery of Pentobarbital Sodium Injection, marketed as Veterinary Fatal Plus, in 250ml vials, strictly adhering to FDA current Good Manufacturing Practices and DEA Schedule C-II regulations for controlled substances. The product is intended for veterinary euthanasia use and must meet all applicable federal standards for potency, purity, labeling, security, and documentation required for Schedule II controlled substances. Production and packaging must ensure traceability, tamper resistance, and compliance with DEA inventory and reporting protocols to prevent diversion or misuse. The solicitation, issued by the Department of Defense under the Medical Supply Chain Pharm FSA, is a subcontract with a performance location at Lackland AFB, Texas, zip code 78236-5638. It was posted on July 30, 2026, with responses due by August 5, 2026. The NAICS code 325412 identifies the industry as pharmaceutical preparations manufacturing. Bidders must demonstrate proven capability in handling regulated veterinary pharmaceuticals, secure supply chain practices, and compliance with federal controlled substance laws. No set-aside provisions are specified, indicating this opportunity is open to all qualified contractors without preference based on size or status.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Isopropyl Alcohol Supply and PackagingThe contract involves the supply, repackaging, labeling, and delivery of USP-grade Isopropyl Alcohol at 99% concentration in 473 mL bottles, requiring full compliance with hazardous material transportation regulations and Department of Defense packaging standards. All activities must ensure the product meets stringent quality and safety requirements for use in medical and defense applications, with packaging designed to withstand transport and storage under military conditions. The work is to be performed at a designated location in Tampa, Florida, with a zip code of 33621. This is a subcontract opportunity issued under NAICS code 325412, which pertains to pharmaceutical and medicinal chemical manufacturing. The solicitation was posted on July 30, 2026, with a response deadline of August 5, 2026. The issuing organization is the Medical Supply Chain Pharm FSA within the Department of Defense, indicating the product is destined for federal medical or operational use. Bidders must be prepared to meet exacting logistics and labeling protocols to ensure seamless integration into DoD supply chains, and all submissions must be completed by the specified deadline for consideration.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BUPIVACAINE AND EPINEP

Solicitation # SPE2DP-26-T-4389

The contract specifies the procurement of bupivacaine and epinephrine injection in 1.8 mL cartridges containing 0.500% w/v bupivacaine hydrochloride and 0.005 mg epinephrine per mL (1:200,000), supplied in lots of 50 cartridges per container, with a total quantity of two containers. The product must be stored at controlled room temperature between 15 and 30 degrees Celsius and maintain a minimum shelf life of 15 months at the time of delivery to the first government activity, despite an 18-month maximum shelf life. All packaging must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must be commercially packaged to ensure protection from damage and safe transport via common carrier at lowest cost to the destination. The material is not considered hazardous under FED-STD-313 and must be packaged in accordance with ASTM D3951, though all DLA Technical and Quality Requirements take precedence. Mercury or mercury-containing compounds are prohibited in direct contact with the product, except for functional uses in batteries, instruments, or sensors as permitted under NAVSEA guidelines. Delivery is required FOB destination within 20 days of order placement to the USS MIGUEL KEITH (ESB-5) in San Diego, California, with no tolerance for quantity variance. The item is identified by NSN 6505-01-189-3973 and referenced under Purchase Request 7017681406, with multiple approved manufacturers listed including DENTAL HEALTH PRODUCTS INCORPORATED, CARESTREAM DENTAL LLC, PATTERSON DENTAL, HENRY SCHEIN, INC., and BENCO DENTAL SUPPLY CO. All packaging and labeling must adhere to DLA Packaging Requirements for Procurement and palletization standards, and shipment details include vessel-specific transport instructions and government-only tracking identifiers.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4392

Carprofen Tablets 100mg are chewable nonsteroidal anti-inflammatory, analgesic, and antipyretic tablets specifically formulated for dogs, supplied in bottles of 60 tablets each. The product is regulated by the FDA and must comply with the DLA Master List of Technical and Quality Requirements, including packaging standards per Medical Marking Standard No. 1 and MIL-STD-2073-1E, with no tolerance for quantity variance. It is classified as a Type I (Code Q) item with a fixed 36-month shelf life that is non-extendable and must be stored at controlled room temperature between 15–30°C (59–86°F). The item is procured under solicitation SPE2DP-26-T-4392 with a delivery requirement of 20 days FOB destination, and inspection and acceptance occur at the delivery point. Only approved manufacturers including Zoetis Inc., Covetrus North America, LLC, and Patterson Veterinary Supply, Inc. with specified part numbers are eligible, and all supplies must be properly marked in accordance with government standards. The contracting official must submit a referral through EBS to confirm product suitability before award, and the item is identified by NSN 6509014874464 under the Department of Defense’s Medical Supply Chain PHARM FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 4 days

AI Contract Overview

The County of Orange’s Health Care Agency is issuing an invitation for competitive bids from qualified vendors to provide pharmaceutical services under a fully electronic procurement process. The solicitation, identified as IFB-042-2900205-AA, emphasizes the importance of submitting bids exclusively through the County’s online bidding system by December 1, 2025, with questions regarding the solicitation due by November 17, 2025. The contract resulting from this process will be a firm fixed fee agreement, with an anticipated start date of March 1, 2026, and a performance period of one year. The scope of work includes supplying pharmaceuticals such as antibiotics, testing supplies, and related medical products, with requirements for same-day delivery within two hours, adherence to pricing benchmarks like Red Book and First DataBank, and compliance with applicable federal, state, and local regulations. The contractual framework incorporates standard terms and conditions tailored to county procurement, including clauses on governing law, amendments, delivery, acceptance, warranties, and non-discrimination. The contract also references attachments detailing the scope of work and payment terms. Evaluation of bids will primarily focus on price, with responsibility and past performance considerations playing a role, alongside preferences for certified small or disadvantaged business entities, such as OCLSB and DVBE firms. Payment will be processed via electronic funds transfer, and the contract stipulates responsibilities for packaging, labeling, and delivery, with specific requirements for pharmaceutical labeling and receipt confirmation. The agreement emphasizes compliance with conflict of interest disclosures, licensing, and operational standards, while final acceptance depends on inspection and testing at the County’s designated location. Overall, this procurement aims to secure reliable pharmaceutical services through a transparent, competitive process that prioritizes cost-effectiveness, responsibility, and regulatory adherence.

General Info

Agency

California → OC Health Care AgencyView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

CA, USA

Set-Aside

NONE

Documents

(2)

IFB042 2900205 AA Pharmaceutical Services Contract

PDF•27 pages•contract-document

IFB042 2900205 AA Pharmaceutical Services Invitation for Bid

PDF•24 pages•ifb

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedNov 3

Solicitation

Response DeadlineDec 1

Deadline has passed

Submission Closed

12/01/2025, 12:00:00 AM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyCalifornia → OC Health Care Agency

Contacts1 person available

OfficeN/A

Organization / Agency

California → OC Health Care Agency

View Agency Profile

Office AddressN/A

Contacts

Abraham Aragon

contact@example.gov

+1 (555) 000-0000

Full Description

The County of Orange, Health Care Agency, (hereinafter referred to as County) is requesting competitive bids from qualified vendors (hereinafter referred to as Bidder) for PHARMACEUTICAL SERVICES. The awarded Contract, (hereinafter referred to as Contract) will be between the County and awarded Bidder, (hereinafter referred to as Contractor) in accordance with the model contract terms, conditions and scope of work. This is a fully electronic solicitation – only electronic bids submitted through the County’s online bidding system will be allowed; no other form of bid submittals will be accepted. Prior to submitting a bid, Bidders are advised to carefully read the instructions below, including the model contract and any solicitation attachments and/or exhibits.All questions or requests for interpretations must be received within this solicitation by Monday, November 17, 2025, before 12:00 am as specified in the solicitation. Respondents are not to contact other County personnel with any questions or clarifications concerning this solicitation.